3-nitropropionic acid has been researched along with creatine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 9 (64.29) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erecińska, M; Nelson, D | 1 |
| Deshpande, SB; Fukuda, A; Nishino, H | 1 |
| Beal, MF; Ferrante, RJ; Jenkins, BG; Kaddurah-Daouk, R; Matthews, RT; Rosen, BR; Yang, L | 1 |
| Beal, MF; Bloch, G; Brouillet, E; Condé, F; Dautry, C; Hantraye, P; Mittoux, V | 1 |
| Chang, C; Lee, WT; Shen, YZ | 1 |
| Dunbar, GL; Haik, KL; Shear, DA | 1 |
| Brustovetsky, N; Brustovetsky, T; Dubinsky, JM | 1 |
| Del Río, P; Massieu, L; Montiel, T | 1 |
| de Boer-Van Huizen, RT; de Waal, RM; Kremer, B; ten Donkelaar, HJ; Verbeek, MM; Vis, JC | 1 |
| Andres, RH; Ducray, AD; Huber, AW; Krebs, SH; Pérez-Bouza, A; Schlattner, U; Seiler, RW; Wallimann, T; Widmer, HR | 1 |
| Andres, RH; Ducray, AD; Qualls, R; Schläppi, JA; Schlattner, U; Seiler, RW; Wallimann, T; Widmer, HR | 1 |
| Gardián, G; Klivényi, P; Kovacs, GG; Oláh, J; Orosz, F; Ovádi, J; Vécsei, L; Westerhoff, HV | 1 |
| Beal, MF; Calingasan, NY; Cormier, K; Ferrante, RJ; Smith, K; Wille, EJ; Yang, L | 1 |
| Beal, MF | 1 |
1 review(s) available for 3-nitropropionic acid and creatine
| Article | Year |
|---|---|
Neuroprotective effects of creatine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Creatine; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Nitro Compounds; Propionates | 2011 |
13 other study(ies) available for 3-nitropropionic acid and creatine
| Article | Year |
|---|---|
Effects of 3-nitropropionic acid on synaptosomal energy and transmitter metabolism: relevance to neurodegenerative brain diseases.
Topics: Adenosine Triphosphate; Animals; Brain Diseases; Cell Death; Creatine; Energy Metabolism; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Glutamine; Guanosine Diphosphate; Guanosine Triphosphate; Lactates; Lactic Acid; Male; Neurotransmitter Agents; Nitro Compounds; Oxygen Consumption; Phosphocreatine; Propionates; Pyruvates; Pyruvic Acid; Rats; Rats, Sprague-Dawley; Synaptosomes | 1994 |
3-Nitropropionic acid increases the intracellular Ca2+ in cultured astrocytes by reverse operation of the Na+-Ca2+ exchanger.
Topics: Animals; Animals, Newborn; Antihypertensive Agents; Astrocytes; Calcium; Carrier Proteins; Cells, Cultured; Cerebral Cortex; Creatine; Fura-2; Image Processing, Computer-Assisted; Neostriatum; Nitro Compounds; Propionates; Rats; Rats, Wistar; Sodium; Sodium-Calcium Exchanger | 1997 |
Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease.
Topics: Adenosine Triphosphate; Animals; Antihypertensive Agents; Antineoplastic Agents; Creatine; Creatinine; Disease Models, Animal; Energy Metabolism; Free Radicals; Huntington Disease; Lactates; Male; Malonates; Neostriatum; Neuroprotective Agents; Neurotoxins; Nitro Compounds; Oxidative Stress; Propionates; Rats; Rats, Sprague-Dawley; Tyrosine | 1998 |
Serial 1H-NMR spectroscopy study of metabolic impairment in primates chronically treated with the succinate dehydrogenase inhibitor 3-nitropropionic acid.
Topics: Animals; Aspartic Acid; Body Water; Cell Count; Choline; Corpus Striatum; Creatine; Immunohistochemistry; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Nitro Compounds; Occipital Lobe; Papio; Phosphocreatine; Propionates; Putamen; Succinate Dehydrogenase; Time Factors | 1999 |
Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid: evaluation by magnetic resonance imaging and in vivo proton magnetic resonance spectroscopy.
Topics: Animals; Aspartic Acid; Behavior, Animal; Brain; Choline; Corpus Striatum; Creatine; Dizocilpine Maleate; Hippocampus; In Vitro Techniques; Lamotrigine; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Neuroprotective Agents; Nitro Compounds; Propionates; Rats; Rats, Sprague-Dawley; Triazines | 2000 |
Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats.
Topics: Animals; Behavior, Animal; Cerebral Ventricles; Cognition Disorders; Corpus Striatum; Creatine; Male; Movement Disorders; Nitro Compounds; Propionates; Rats; Rats, Sprague-Dawley | 2000 |
On the mechanisms of neuroprotection by creatine and phosphocreatine.
Topics: Animals; Cells, Cultured; Corpus Striatum; Creatine; Dietary Supplements; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glutamic Acid; Hippocampus; Mitochondria; Neurons; Neuroprotective Agents; Nitro Compounds; Permeability; Phosphocreatine; Propionates; Rats; Rats, Sprague-Dawley | 2001 |
Neurotoxicity of glutamate uptake inhibition in vivo: correlation with succinate dehydrogenase activity and prevention by energy substrates.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Amino Acid Transport System X-AG; Animals; Brain Ischemia; Convulsants; Creatine; Dicarboxylic Acids; Drug Interactions; Energy Metabolism; Excitatory Amino Acid Antagonists; Glutamic Acid; Male; Neostriatum; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Neurotransmitter Uptake Inhibitors; Nitro Compounds; Propionates; Pyrrolidines; Pyruvic Acid; Rats; Rats, Wistar; Succinate Dehydrogenase | 2001 |
Creatine protects against 3-nitropropionic acid-induced cell death in murine corticostriatal slice cultures.
Topics: Animals; Apoptosis; Cell Death; Cerebral Cortex; Corpus Striatum; Creatine; Mice; Mice, Inbred BALB C; Neuroprotective Agents; Nitro Compounds; Organ Culture Techniques; Propionates | 2004 |
Effects of creatine treatment on survival and differentiation of GABA-ergic neurons in cultured striatal tissue.
Topics: Animals; Cell Differentiation; Cell Survival; Cells, Cultured; Corpus Striatum; Creatine; Creatine Kinase; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Drug Administration Schedule; gamma-Aminobutyric Acid; Glucose; Isoenzymes; Mitogen-Activated Protein Kinases; Neurons; Neurotoxins; Nitro Compounds; Phosphatidylinositol 3-Kinases; Propionates; Rats; Rats, Wistar; Stem Cells; Tissue Distribution | 2005 |
Creatine treatment promotes differentiation of GABA-ergic neuronal precursors in cultured fetal rat spinal cord.
Topics: Animals; Blotting, Western; Cell Differentiation; Cell Survival; Cells, Cultured; Choline O-Acetyltransferase; Creatine; Creatine Kinase; Energy Metabolism; Female; gamma-Aminobutyric Acid; Immunohistochemistry; Mitogen-Activated Protein Kinase 1; Neurons; Nitro Compounds; Pregnancy; Propionates; Rats; Spinal Cord; Stem Cells; Tetrazolium Salts; Thiazoles; Tubulin | 2007 |
Increased glucose metabolism and ATP level in brain tissue of Huntington's disease transgenic mice.
Topics: Adenosine Triphosphate; Animals; Brain; Creatine; Female; Glucose; Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating); Glycolysis; Huntingtin Protein; Huntington Disease; Male; Mice; Mice, Transgenic; Mitochondria; Nerve Tissue Proteins; Nitro Compounds; Nuclear Proteins; Propionates | 2008 |
Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 8-Hydroxy-2'-Deoxyguanosine; alpha-Synuclein; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Creatine; Deoxyguanosine; Disease Models, Animal; Dopamine; Drug Therapy, Combination; Glutathione; Glutathione Disulfide; Huntington Disease; Lipid Peroxidation; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitro Compounds; Parkinson Disease; Propionates; Rats; Rats, Inbred Lew; Tyrosine 3-Monooxygenase; Ubiquinone | 2009 |